- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 14/56 - IFN-alpha
Patent holdings for IPC class C07K 14/56
Total number of patents in this class: 558
10-year publication summary
|
29
|
31
|
38
|
34
|
38
|
55
|
37
|
32
|
39
|
13
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vib VZW | 799 |
34 |
| Universiteit Gent | 1276 |
33 |
| Orionis Biosciences BV | 73 |
27 |
| Orionis Biosciences Inc. | 84 |
21 |
| Centre National de La Recherche Scientifique | 9632 |
20 |
| Modernatx, Inc. | 1181 |
18 |
| Centre hospitalier Regional universitaire de Montpellier | 30 |
15 |
| Teva Pharmaceuticals Australia Pty Ltd | 29 |
13 |
| IBC Pharmaceuticals, Inc. | 99 |
12 |
| CytomX Therapeutics, Inc. | 205 |
11 |
| Universite de Montpellier | 920 |
11 |
| ILC Therapeutics Ltd | 28 |
10 |
| Glaxo Group Limited | 4496 |
9 |
| Rutgers, The State University of New Jersey | 1776 |
8 |
| Ubiprotein, Corp. | 10 |
8 |
| The Regents of the University of California | 18943 |
7 |
| President and Fellows of Harvard College | 5792 |
7 |
| Biosteed Gene Expression Tech. Co., Ltd. | 12 |
6 |
| Bioverativ Therapeutics Inc. | 220 |
6 |
| Hanmi Science Co., Ltd. | 145 |
6 |
| Other owners | 276 |